Wave Life Sciences stock jumps 17% as obesity gene-silencing race heats up
New York, January 6, 2026, 11:28 EST — Regular session Wave Life Sciences Ltd shares (WVE.O) jumped about 17% on Tuesday, extending sharp swings in the obesity drug trade as investors sized up the next set of clinical readouts. The stock was up 17.2% at $17.58 in morning trade on Nasdaq, after moving between $14.15 and $19.49, with about 7.0 million shares traded. The move shows how quickly sentiment can shift in obesity-linked biotechs, where small early-stage updates often drive outsized price action. Investors are hunting for approaches that can cut harmful fat while preserving muscle, a sticking point for